AB
AEON BiopharmaClinical-stage biopharmaceutical company developing ABP-450 (prabotulinumtoxinA), a biosimilar to Botox, for therapeutic indications like cervical dystonia and chronic migraine.
1 Pulse story
S
SanofiSanofi is a global biopharmaceutical company developing and manufacturing medicines and vaccines across specialty care, immunology, oncology, and rare diseases.
2 Pulse stories
Total RaisedNot disclosed
Last ValuationNot disclosed
Biotech
Sector
Biotech
2013
Founded
1973
Irvine, California
HQ
Paris, France
Public (AEON)
Status
Public (SNY)
AEON Biopharma investors
No investors on record.
Sanofi investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for AEON Biopharma and Sanofi.